Treatment And Delay Of Onset Of Synucleinopathic And Amyloidogenic Disease

Abstract

The invention provides improved agents and methods for treatment of diseases associated with synucleinopathic diseases, including Lewy bodies of alpha-synuclein in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the Lewy body. The methods are particularly useful for prophylactic and therapeutic treatment of Parkinson's disease.


Claims
Download PDF
Document Preview
Document History
  • Publication: Apr 5, 2011
  • Application: Aug 20, 2007
    US US 84205407 A
  • Priority: Sep 2, 2009
    US US 66001509 A
  • Priority: Aug 20, 2007
    US US 84205407 A
  • Priority: Apr 6, 2007
    US US 69764607 A
  • Priority: Feb 23, 2007
    US US 71024807 A
  • Priority: Aug 9, 2005
    US US 2005/0028166 W
  • Priority: Jul 19, 2005
    US US 18590705 A
  • Priority: Aug 9, 2004
    US US 91521404 A
  • Priority: Oct 31, 2003
    US US 69951703 A

Download Citation


Sign in to the Lens

Feedback